Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Nov 18, 2009
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Other
Common Stock
2009-11-16$9.91/sh+1,096$10,862→ 79,648 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 16, 2009.